Fasenra 30 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FDQZR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,887
Award facts
- Contract value 100% obligated
- $4,887.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,887.00 by the Defense Logistics Agency (DLA) on August 27, 2025. The contract calls for the delivery of Fasenra 30 mg/ml syringes, a biologic medication used in the treatment of severe eosinophilic asthma. The award carries no set-aside designation and has an ultimate completion date of August 28, 2025, with performance occurring at the contractor's Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing delivery orders for branded medications, biologics, and specialty pharmaceutical products to support military health system operations.
Quick answers
Who was awarded contract SPE2DB25FDQZR?
SPE2DB25FDQZR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FDQZR worth?
The government has obligated $4,887 on SPE2DB25FDQZR.
Is contract SPE2DB25FDQZR an order under another contract?
Yes. SPE2DB25FDQZR is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDQZR competed?
The extent of competition for SPE2DB25FDQZR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award